SK BACKER, D. A. u. S. K. LUDWIN (1987):
Blood-brain barrier permeability during Cuprizone induced demyelination. Implikations for the pathogenesis of immune-mediated demyelinating diseases.
J Neurol. Sci. 78: 125-37
BARANZINI, S. E., C. IFSTROM, S-Y. HANGS, C. UTUNOI, R. URRAY, R. IGUCHI, J.R.KSENBERG (2000):
Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern ofcytokine expression.
J. Immunol. 165: 6576-6582
BARKHOF F., J-H.T.M. VAN WAESBERGHE, M. FILIPPI, T. YOUSRY, D.H.
MILLER, D. HAHN, A. J.THOMSON, L. KAPPOS, P. BREX, C.POZILLI, C.H.
POLMAN, FOR THE EUROPEAN STUDY GROUP ON INTERFERON BETA-1B IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (2001):
T1 hypointense lesions in secondary progressive multiple sclerosis; effect of interferon beta-1b treatment.
Brain 124: 1396-402
BAUMANN N. u. D.PHAM-DINH (2001):
Biology of oligodendrocyte and myelin in the mammalian central nervous system.
Physiological Reviews 81: 871-927
BILLIAU A., B.C. KIESEIER, H. P. HARTUNG (2004):
Biologic role of interferon beta in multiple sclerosis.
J. Neurol. 251: II10-14
BITSCH A., C. DA COSTA, S. BRUNKOWSKI, F.WEBER, P. RIECKMANN, W.
BRUCK (1998):
Identification of macrophage populations expressing tumor necrosis factor- alpha mRNA in acute multiple sclerosis.
Acta Neuropathol. (Berl) 95: 373-377
BJATMAR C., G. KIDD,S. MÖRK, R. RUDICK, B.D. TRAPP (2000):
Neurological diability correlates with spinal cord axonal loss and reduced N-acatyl aspartate in chronic multiple sclerosis patients.
Ann. Neurol. 48: 893-901
BLAKEMORE W.F.(1972):
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in Cuprizone intoxication in mice
J Neurocytol. 1: 413
BLAKEMORE W.F. (1973):
Demyelination of the superior cerebellar peduncle in the mouse induced by Cuprizone.
J Neurol. Sci 20: 63
BLAKEMORE W.F., H.S. KEIRSTEAD (1999):
The origin of remyelinating cells in the central nervous system.
J. Neuroimmunol. 98: 69-76
BLAKEMORE WF (1974):
Pattern of remyelination in CNS.
Nature 249: 577-578
BOTTREL R.L.A., Y. YANG, D.E. LEVY, M. TOMAY, L.F.REIS (1999):
The immune response modifier imiquimod requires STAT-1 for induction of interferon, interferon-stimulated genes, and interleukin-6.
Antimicrob. Agents Chemother. 43: 856-861.
BOUTROS T. E. CROZE, V. W. YONG (1997):
Interferon-β is a potent promoter of nerve growth factor production by astrocytes.
J.Neurochem. 69: 939-946
BROWN K. A. (2001):
Factors modifying the migration of lymphocytes across the blood-brain barrier.
Int. Immunopharmacol. 1: 2043-2062
H BRÜCK W., M. SCHMIED, G. SUCHANEK, Y. BRÜCK, H. BREITSCHOPF, S, POSER, S. PIDDLESDEN, H. LASSMANN (1994):
Oligodendrocytes in the early course of multiple sclerosis.
Ann. Neurol. 35: 65-73
BUTT A. M., M. IBRAHIM, F.M. RUGE, M. BERRY (1995):
Biochemical subtypes of oligodenrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody. Rip.
Glia 14: 185-197
CALABRESI P. A., K.R. TRANQUILL, J.M: DAMBROSIA, L:A. STONE, H. MALONI, C:N: BASH, J.A. FRANK, H.F. MC FARLAND (1997):
Increase in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta 1b.
Ann Neurol. 41: 669-674
CAMERONCURRY P., N. LE DOUARIN (1995):
Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord. Neuron 15: 1299-1310
CAMMER W. (1999):
The neurotoxicant cuprizone retards the differentiation of oligodendrocytes in vitro.
J. Neurol. Sci. 168: 116-20
CARLTON W.W. (1969):
Spongiform encephalopathy induced in rats and guinea pigs by cuprizone.
Exp. Mol. Pathol. 10: 274
CENCI DI BELLO I., M. R. L. DAWSON, J.M. LEVINE, R. REYNOLDS (1999):
Generation of oligodendroglial progenitors in acute inflammtory demyelinating lesions of the rat brain stem is stimulated by demyelination rather than inflammation.
J. Neurocytol. 28: 366-381
CHABOT S., G. WILLIAMS, V.W. JONG (1997):
Microglia production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferon-beta 1b.
Clin. Inest. 100: 604-612
CHABOT S., V.W. JONG (2000):
Interferonbeta-1b increases interleukin 10 in a model of T-cell microglia interaction.
Neurology 55: 1497-1505
CHANG A., A. NISHIYAMA, J. PETERSON, J. PRINEAS, B. D.TRAPP (2000)
NG2-positive oligodendrocyte progenitors cells in adult human brain and multiple sclerosis lesions.
J. Neurosci. 20, 6404-6412
CHANG A., W. W. TOURTELLORTE, R. RUDICK, B. D.TRAPP (2002):
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
N Engl. J. Med. 346: 199-200
COMPSTON A., A. COLES (2002):
Multiple sclerosis.
The Lancet 359: 1221-1231
COSSINS J. A., J. M. CLEMENTS, J FORD, K. M.MILLER , R. PIGOTT, W. VOSS, P.
VAN DER VALK, C. J. DE GROOT (1997):
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions.
Acta Neuropathol. (Berl) 94: 590-598
CULZNER M. L., D. GVERIC, C. STRAND, A. J. LOUGHLIN, L. PEAMEN, G.
OPDENACKER, J. NEWCOMBE (1996):
The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution.
J Neuropathol Exp Neurol. 55: 1194-1204
DAWSON M. R. L., J.M. LEVINE, R. REYNOLDS (2000):
NG2-expressing cells in the central nervous system: are they only oligodendroglial progenitors.
J. Neurosci. Res. 61: 471-479
DE STEFANO N., P. M. MATTHEWES, F. LIQUN, S. NARAYANAN, J. STANLEY, G.
S. FRANCIS, J. P. ANTEL, D. L. ARNOLD (1998):
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
Brain 121: 1469-1477
DHIB-JALBUT S. (2002):
Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.
Neurology 58: 3-9
DOETSCH F., J. M. GARCIA-VERDUGO, A. ALVAREZ-BUYLLA (1997):
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain.
J. Neurosci. 17: 5046-5061
DUBOIS-DALC M., T. BEHAR, L. HOUDSON, R. A. LAZZARINI (1986):
Emergence of three myelin proteins in oligodendrocytes cultured without neurons.
J. Cell. Biol. 102: 384-392
ERLANDSSON L., R. BLUMTHAL, M. L. ELORATA, H. ENGEL, G.ALM, S.WEISS, T. LEANDERSSON (1998):
Interferon-β is required for interferon-α production in mouse fibroblasts.
Curr. Biol. 8:223-226
ESPINOSA DE LOS MONTEROS A., M. ZHANG, J. DE VELLIS (1993):
O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes.
Proc. Natl. Acad. Sci. USA 90: 50-54
FRANKLIN R. J. M. (2002):
Why does remyelination fail in multiple sclerosis?
Nat. Rev. Neurosci. 3: 705-14
FROST E.,B. KIERNAN, A. FAISSNER, C. FRENCH-CONSTANT (1996):
Regulation of oligodendrocyte precursor migration by extracellular matrix: evidence for substrate-specific inhibition of migration by tenascin-C.
Dev. Neurosci. 18: 266-273
FUJITA N., H. ISHIGURO (1990):
Induction of myelin associated glycoprotein mRNA in experimental remyelination.
Brain Res. 513: 152-155
GADIENT R. A., U.H. OTTEN (1997):
Interleukin-6 (IL-6) a molecule with both beneficial and destructive potential.
Prog. Neurobiol. 52: 379-390
GARD A. L., S. PFEIFFER (1993):
Glial cellmitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors.
DEV Biol. 159: 618-630
GIACOMINI P., R. TECCE, R. GAMARI, A. SACCHI, P. B. FISCHER, P. G. NATALI (1988):
Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded gycoproteins by a protein synthesis-dependent mechanism.
J. Immunol. 140: 3073-81
GILKUN-SHERKI Y., E. MELAMED, D. OFFEN (2004):
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapiy.
J. Neurol. 251: 261-268
GOLD R. u. P. RIECKMANN (2000):
Pathogenese und Therapie der Multiplen Sklerose 2.Auflage- Bremen:
UNI-MED ISBN 3-89599-484-7
HALFPENNY C. A., N. J. SCOLDING (2003):
Immune-modifying agents do not impare the survival, migration or proliferation of oligodendrocyte progenitors (CG4) in vitro.
J. of Neuroimmunology 139: 9-16
HARDY R. u. R. REYNOLDS (1993):
Neuron- oligodendroglial interactions during central nervous system development.
J. Neurosi. Res. 36: 121-126
HARTUNG H. P., A. BAR-OR, Y. ZOUKOS (2004):
What do we know about the mechanism of action of disease-modifying treatments in MS?
J. Neurol. 251: V/12-V/29
HEINE S., J. EBNET, S. MAYSAMI, M. STANGEL (2006):
Effects of interferon-beta on oligodendroglial cells.
Journal of Neuroimmunology 177:173-180
HIREMATH M. M.u. Y. SAITO (1998):
Microglial/macrophage accumulation during cuprizone –induced demyelination in C57BL/6 mice.
Journal of neuroimmunology 92: 38-49
HUA L. L. u. S. C. LEE (2000):
Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia.
Glia 30: 74-81
IGLESIAS A., J. BAUER, T. LITZENBURGER, A. SCHUBART, C. LININGTON (2001):
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
Glia 36: 220-234
JOHE K. K., T. G. HAZEL, T. MULLER, M. M. DUGICH-DJORDJEVIC, R. D. G.MC KAY (1996):
Single factors direct the differenciation of stem cells from the fetal and adult central nervous system.
Genes Dev.10: 3129-3140
KARP C. L., D. A. BIRON, D. N. IRANI (2000):
Interferon b in multiple sclerosis: is IL-12 suppression the key?
Immunol. Today 21: 24-28
KAWANOKUTSCHI J., T. MIZUNO, H. KATO, N. MITSUMA, A. SUZUMARA (2004):
Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central nervous system.
Neuropharmacology 46: 734-742
KEIRSREAD H. S., J. M. LEVINE, W. F. BLAKEMORE (1998a):
Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord.
Glia, 22: 161-170
KENNEL DE MARCH A., M. DE BOUWERIE, Kolopp-Sarda M. N. KOLOPP-SARDA, G. C. FAURE, M. C. BENE, C. C. BERNARD (2003):
Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiplöe sclerosis.
J Neuroimmunol 135: 117-125
KERSTNSON J. W., CARLTON W. W. (1971):
Histopathologic and enzyme histochemical observationms of the cuprizone-induced brain edema.
Exp. Mol. Pathol. 15:82
KIESEIER B. C., R. KIEFER, J. M. CLEMENTS, K. MILLER, G. M. WELLS, T.
SCHWEITZER, A. J. GEARING, H. P. HARTUNG (1998):
Matrix metalloproteinase-9 and –7 are regulated in experimental autoimmune enzephalomyelitis.
Brain 121: 159-166
KIM M. O., Q. SI , J.N. ZHOU, R. G. PESTELL, C. F. BROSNAN, J. LOCKER, S. C.
LEE (2002):
Interferon- β activates multiple signaling cascades in primary human microglia.
Journal of Neurochemistry 81: 1361-1371
KKOMOLY S.u. M. JAGASINGHAM (1987):
Decrease in oligodendrocyte carbonic anhydrase activity preceding myelin degeneration in cuprizone induced demyelination.
J. Neurol. Sci. 79: 141-148
KORNEK B., M. K. STORCH, R. WEISSERT, E. WALLSTROEM, A. STEFFERL, T.
OLSSON, C. LININGTON, M. SCHMIDBAUER, H. LASSMANN (2000):
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis.
Am.Jour. of Pathology 157: 267-274
KUHLMANN T., G. LINGFELD, A. BITCH, J. SCHUCHARD, W. BRÜCK (2002):
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.
Brain 125: 2202-2212
LACHAPELLE F., M GUMPEL., M. BAULACK, C. JACQUE, P. DUC, N. BAUMANN (1983):
Transplantation of the CNS fragments into the brain of shiverer mutant mice: extensuive myelination by implanted oligodendrocytes. I. Immunohistochemical studies.
Dev. Neurosci. 6: 325-334
LEPPERT D., E. WAUBANDT, M. R. BURK, J. R. OKSENBERG, S. L. HAUSER (1996):
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Ann neurol. 40: 846-852
LEVINE J. M.u. R. REYNOLDS (1999):
Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination.
Exp. Neurol. 160: 333-347
LEVINE J. M, F. STINCONE, Y. S. LEE (1993):
Development and differentiation of glial precursor cells in the rat cerebellum.
Glia 7: 307-321
LEVISON S. W.u. J. E. GOLDMANN (1993):
Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat brain.
Neuron 10: 201-212
LO TURCO J. J. (2000):
Neural circuits in the 21st century: synaptic networks of neurons and glia.
Proc. Natl. Acad. Sci. USA 97: 8196-8197
LOCK C., G. HERRMANNS, R. PEDOTTI, A. BREDOLAN, E. SCHADT, H. GARREN, A. LANGER-GOULD, S. STOBER, B. CANELLA, J. ALLANRD, P. KLONOWSKI, A.
AUSTIN, N. LAD, N. KAMINSKI, S. J. GALLI, J. R. OKSENBERG, C. S. RAIN, R.
HELLER, L. STEINMANN (2002):
Gene- microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalitis.
Nature Med 8: 500-507
LOVE S. (1988):
Cuprizone neurotoxicity in the rat: morphologic observations J Neurol. Sci. 84: 23-37
LUCHINETTI C., W. BRÜCK, J. PARISI, B. SCHEIDTHAUER, M. RODRIGUEZ, H.
LASSMANN (1999):
A quantitative analysis of oligodendrocytes in multiple sclerosis. A study of 113 cases.
Brain 122: 2279-2295
LUCHINETTI C., W. BRÜCK, J. PARISI, B. SCHEIDTHAUER, M. RODRIGUEZ, H.
LASSMANN (2000):
Heterogeneity of multiple sclerosis lesions: implikations for the pathogenesis of demyelination.
Ann. Neurol. 47: 707-717
LUDWIN S. K. (1978):
Central nervous system demyelination and remyelination in the mouse.
Laboratory investigation 39: 597-612
LUDWIN S. K (1980):
Chronic demyelination inhibits remyelination in the central nervous system.
Laboratory investigation 43: 382-387
LUDWIN S. K (1994):
Central nervous system remyelination: studies in chronically damaged tissue Annals of Neurology 36: 143-145
LUDWIN S. K (1997):
The pathobiology of the oligodendrocyte.
J Neuropathol Exp. Neurol. 56: 111-124
MAEDA Y., M. SOLANKY, J. MENONNA, J.CHAPIN, W. LI, P. DOWLING (2001) Platlet derived growth factor-αreceptor-positiv oligodendroglia are frequent in multiple sclerosis lesions.
Ann. Neurol. 49, 776-785
MA Z., H. QIN, E. N. BENVENISTE (2001):
Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-β: critical role of STAT-1α.
J. Immunol. 167: 5150-5159
MASTRONARDI F. G., W. MIN, H. WANG, S. WINER, M. DOSCH, J. M. BOGGS, M.
A. MOSCARELLO (2004):
Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-β plus Vitamin B12: treatment to modify notch-1/sonic hedgehog balance.
J. Immunol. 172: 6418-6426
MATSUSCHIMA G. K., P. MORELL (2001):
The neurotixicant,cuprizone, as a model to study demyelination and remyelination in the central nervous system.
Brain Pathol. 11: 107-116
MC CARTHY u. DE VELLIS (1980):
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.
J. Cell Biology 85: 890-902
MCMANUS C. M., J. S. H. LIU, M. T.. HAHN, L. L. HUA, C. F. BROSNAN, J. W.
BERNAN, S. C. LEE (2000):
Differential induction of chemokines in human microglia by Type I and Type II interferons.
Glia 29: 273-280
MERILL J. E u. SCOLDING N. L. (1999):
Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease.
Neuropathol. Appl. Neurobiol. 25: 435-458
MILLER R.H. (1996):
Oligodendrocyte origins.
Trends Neurosci. 19: 92-96
MILNER R., H. J. ANDERSON, R. F. RIPPON, J. S. MC KAY, R. J. FRANKLIN, M. A.
MARCHIONNI, R. REYNOLDS, C. FRENCH-CONSTANT (1997):
Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration
Glia 19: 85-90
MONGE M., D. KADINSKI, C. M. JACQUE, B. ZALC. (1986):
Oligodendroglial expression and deposition of four myelin constituents in the myelin sheath during development. An in vivo study.
Dev Neurosci. 8: 222-226
MORELL P., C. V. BARETT, J. L. MASON, A. D. TOEWS, J. D. HORSTETTLER, G.
W. KNAPP, G. K . MATSUSCHIMA (1998):
Gene expression in brain during cuprizone-induced demyelination and remyelination Mol.
Cell Neurosci. 12 :200-207
NEUMANN H., I. M. MEDANA, J. BAUER, H. LASSMANN(2002):
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.
Trends Neurosci. 25: 313-319
NISHIYAMA A., X. H. LIN, N. GIESE, C. H. HELDIN, W. STALLCUP (1996a):
Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain.
J. Neurosci. Res. 43: 299-314
NJIENGA M. K., M. J. COENEN, N. DE CUIR, H. Y. YEH, M. RODRIGUEZ (2000):
Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis.
J. Neurosci. Res. 59: 661-670
NORONHA A., A. TOSCAS, M. A. JENSEN (1993):
Interferon β decreases T cell activationnand interferon γ production in multiple sclerosis J. Neuroimmunol. 46:145
OKADA K., E. KURODA, Y. YOSHIDA, U. YAMASHITA, A. SUZUMURA, S. TSUJI (2005):
Effects of Interferon-β on the cytokine production of astrocytes.
Journal of Neuroimmunology 159: 48-54
ONG W. Y., J. M. LEVINE (1999):
A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus.
Neuroscience 92: 83-95
ORENTAS D. M.u. R. H. MILLER (1996):
The orign of the spinal cord oligodendrocytes is dependent on local influences from the notochord.
Dev Biol 177: 43-53
OZAWA K., G. SCHUCHANEK, H. BREITSCHOPF, W. BRÜCK, H. BUDKA, K.
JELLINGER, H. LASSMANN (1994):
Patterns of oligodendroglia pathology in multiple sclerosis.
Brain 117: 1311-1322
PALMER T. D., J. TAKAHASHI, F. H. GAGE (1997):
The adult rat hippocampus contains primordial neural stem cells.
Mol.Cell. Neurosci. 8: 389-404
PASSAQUIN A. C., G. COUPIN, W. A. SCHREIer, P.POINDRON, R. A. COLE,DE J.
VELLIS (1989):
Interferon inhibits the accumulation of glycerolphosphate dehydrogenase mRNA in oligodendrocytes and C6 cells.
Neurochem. Res. 14: 987-993
PATTISON I. H. u. J. N. JEBETT (1971):
Histopathological similarities between scrapie and cuprizone toxicity in mice.
Nature 230:115
PETERS A. (2004):
A fourth type of neuroglial cell in the adult central nervous system.
J. Neurocytology 33: 345-357
PFEIFFER S. E., A. E. WARRINGTON, R. BANSAL (1993):
The oligodendrocyte and its many cellular processes.
Trends Cell. Biol. 3: 191-197
POSER C. M., J. WIKSTROM, H. J. BAUER (1979):
Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system.
J. Neurol. Sci.40,159-168
POULY S:, B. BECHER, M. BLAIN, J. P. ANTEL (1999):
Expression of a homologue of rat NG2 on human microglia.
Glia 27: 259-268
POULY S, A. PRAT, M. BLAIN, A. OLIVER, J. P. ANTEL (2001):
NG2 immunoreactivity on human brain endothelial cells.
Acta Neuropathol. (Berl) 102: 313-320
PRINEAS J. W., R. O. BARNARD, E. E. KWON, L. R. SHARER, E-S. CHO (1993):
Multiple sclerosis: remyelination of nascent lesions.
Ann.Neurol. 33: 137-151
QIN Y. u. P. DUQUETTE (2003):
B-cell immunity in MS.
Int. MSJ. 10: 110-120
RAFF M. C., L. E. LILLIEN, W.D. RICHARDSON, J. F. BURNE, M. D. NOBLE (1988):
Platelet-derived growth factor from astrocytes driven the clock that times oligodendrocyte development in culture.
Nature 333: 562- 565
RALNE C. S. u. E. WU (1993):
Multiple sclerosis; remyelination in acute lesions.
J. Neuropathol. Exp. Neurol. 52: 199-204
RAMON Y. u. S. CAJAL (1913):
Contribucion al conocimiento de la neuroglia del cetrebro humano.
Trab. Lab. Invest. Biol. 11: 255-315
REYNOLDS R., M. DAWSON, A. POLITO, I. CENCI DI BELLO, Papadopulos D, D.
PHAM-DINH, J. LEVINE (2003):
The response of NG2-expressing oligodebdrocyte progenitors to demyelination in MOG-EAE and MS.
J. Neurocytol. 31:523-536
REYNOLDS R, G. P. WILKIN (1988):
Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell.
Development 102: 409-425
REZZONICO R., V. IMBERT, R. CHICHEPORTICHE, J. M. DAYER (2001):
Ligation of CD11b and CD11c beta (2) integrins by antibodies or soluble DC23 induces macrophage inflammatory protein 1 alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclearfactor-kappaB.
Blood 97: 2932-2940
RICHARDSON P. M., U. M. MC GUINESS; A. J. AGUAYO (1980):
Axons from CNS neurons regenerate into PNS grafts.
Nature 284: 264-265
RICHARDSON W. D., N. PRINGLE, Mosley ML, B. WESTERMARK, M. DUBOIS-DALQ (1988):
A role for platlet- derived growth factor in neuronal gliogenesis in the central nervous system.
Cell 53: 309-319
RIDER J. L., S. K. MALHORTA, A. PRIVAR, F.H. GAGE (1997).
Reactive astrocytes: Cellular and molecular clues to biological function.
Trends Neurosci. 20: 570-7
RIO HORTEGA D. P. (1921):
Histogenesis y evolucion normal; exodo y distriducion regional de la microglia.
Memor Real Soc. Esp Hist. Nat. 11: 213-268
ROBINSON S., M. TANI, R. M. STRIETER, R. M. RANSOHOFF, r R. H. MILLER (1998):
The chemokine groth-regulated oncogene-α promotes spinal cord oligodendrocyte precursor proliferation.
J. Neurosci. 15: 10457-10463
ROSEN C. L. ,BUNGE R. P., M. D. ARD, P. M. WOOD (1989):
Type 1 astrocytes inhibit myelination by adult rat oligdendrocytes in vitro.
J. Neurosci. 9: 3371-9
ROSS T. M., P. M. MARTINEZ, J. C. RENNER, R. G. THORNE, L. R. HANSON, W. H.
FREY (2004):
Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasiv treatment stategy for multiple sclerosis.
J.Neuroimmunol. 151: 66-77
RUFFINI F., T. E. Kennedy, J. P. ANTEL (2004):
Inflammation and remyelination in the central nervous system: a tale of two systems.
Am. J. Pathol. 164: 1519-1522
SCOLDING N. J. (1998):
Glial precursor cells in the adult human brain.
Neuroscience 4, 264-272
SIDMANN R. L. ,J. B. ANGVINE, Taber Pierce Jr. E. TABER-PIERCE (1971):
Atlas of the Mouse Brain and Spinal Cord
A Commonwealth Fund Book, Harvard University Press, SBN 674-05225-0
SMALL R. K., P. RIDDLE, M. NOBLE (1987):
Evidence for migration of oligodendrocyte –type –2 astrocyte progenitor cells into the developing rat optic nerve.
Nature 328: 155-157
SOLLY S. K., J. L. THOMAS, M. MONGE, C. DEMERENS, C. LUBETZKI, M. V.
GARDINIER, J. M. MATTHIEU, B. ZALC (1996):
Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition.
Glia 18: 39-48
SOMMER I., M. SCHACHNER (1981):
Monoclonal antibodies (01to 04) to oligodendrocyte cell surfaces an immunocytological study in the central nervous system.
Dev Biol 83: 311-327
SORENSEN T. L., Tani M. TANI, J. JENSEN, V. PIERCE, C. LUCHINETTI, V. A.
FOLEIK, S. QIN, J. ROTTMANN, F. SELLEBJERK, R. M. STRIETER, Frederiksen JL, R. M. RANSOHOFF (1999):
Expression of specific chemokinesand chemokine receptors in the central nervous system of multiple sclerosis patients.
J. Clin. Invest.103: 807-815
SPRINKLE T. J. (1989):
2`,3`-Cyclic nucleotide-3-posphodiesterase, an oligodendrocyte-Schwann cell and myelin- associated enzyme of the nervous system.
Crit. Rev. Neurobiol. 4: 235-301
STALLCUP W., BEASLEY (1987):
Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan.
J. Neurosci. 7: 2737-2744
STANGEL M., H. P:HARTUNG (2002):
Remyelination strategies for the treatment of multiple sclerosis.
Prog. in Neurobiology 68: 361-376
STANGEL M, H. LASSMANN (2003):
Multiple Sklerose: Pathologie und Regeneration.
Nervenheilkunde 22: 8-12
STANGEL M., D. BERNHARD (2003):
Polyklonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures:
implications for remyelination.
J. Neuroimmunol. 138: 25-30
STWEART V. C., G. GIOVANNI, J. M. LAND, W. I. MC DONALD, J. B. CLARK, S. J.
R. HEALES (1997):
Pretreatment of astrocytes with interferon-α/β impairs interferon-γ induction of nitric oxide synthase.
J Neurochem. 68: 2547-2551
STUVE O., N. P. DOOLEY, J. H. UHM , J. P. ANTEL, G. S. FRANCIS, G. WILLIAMS, V. W. YONG (1996):
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.
Ann Neurol. 40: 853-63
SUZUKI K., KIKKIWA Y. (1969):
Status spongiosus of CNS and hepatic changes induced by cuprizone.
Am J Pathol 54: 307
TAKAOKA A., Y. MITANI, H. SUEMORI, M. SATO, T. YOKOCHI, S. NOGUCHI, N TANAKA., T. TANIGUCHI (2000):
Cross talk between interferon-gamma and alpha/beta signaling componenzts in caveolar membrane domains.
Sience 288: 2357-2360
TEIGE I., A. TRESCHOW, A. TEIGE, R. MATTSSON, V. NAVIKAS, T.
LEANDERSON, R. HOLMDAHL, S. ISSAZADEH-NAVIKAS (2003):
IFN-β gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
J. of Immun.170: 4776-4784
TRAPP B. D., L. BO, S. MORK, A.CHANQ (1999):
Pathogenesis of tissue injury in MS lesions.
J. Neuroimmunol. 98: 49-56
TRAPP B. D, A. NISHIYAMA, D. CHENG, W. MACKLIN (1997):
Differentiation and death of premyelinating oligodendrocytes in developing rodent brain.
Cell. Biol. 137: 459-468
TRAPP B. D, J. PETERSON, R.M. RANSOHOFF, R. RUDICK, S.MÖRK, L: BÖ (1998):
Axonal transection in the lesions of multiple sclerosis.
N. Engl. J. Med. 338: 278-328
TRAPP B. D, R.M. RANSOHOFF, R. RUDICK (1999):
Axonal pathology in multiple sclerosis: relationship to neurologic disability.
Curr. Opin. Neurol. 12: 295-302
TREBST C., H. WIENDL, M. STANGEL (2006):
Konzepte zur Läsionsentstehung bei Multipler Sklerose.
Der Nervenarzt 77: 158-164
TSAI H-H., E. FROST, V. TO, S. ROBINSON, C. FRENCH-CONSTANT, R.
GEERTMANN, R. M. RANSOHOFF, R. H. MILLER (2002):
The chemokine receptor CXCR2 controls positioning of oligodendrocyte pecursors in developing spinal cord by arresting their migration.
Cell 110: 373-383
VENTURINI G. (1973):
Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo.
J. Neurochem. 21:1147-1151
VIEHOVER A., R. H. MILLER, S-K. PARK, G. FISCHBACH, T. VARTANIAN (2001):
Neuregulin; an oligodendrocyte growth factor absent in active multiple sclerosis lesions.
Dev. Neurosci. 23: 377-86
VOGEL U. S., R. J. THOMPSON (1988):
Molecular structure, localization and possible functions of the myelin- associated enzyme 2`3`- cyclic nucleotide-3`-phosphodiesterase.
J. Neurochem. 50: 1667-1677
WALSHE (1995):
Copper: not too little, not too much, but just right.
JR Coll. Phys. Lond. 29: 280-283
WATANABE M., Y. TOYAMA, A. NISHIYAMA (2002):
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion.
J. Neurosci. Res. 69: 826-836
WEISS S., C.DUNNE, J.HEWSON, C. WOHL, M.WHEATLEY, A. C. PETERSON, B.
A. REYNOLDS (1996):
Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis.
J. Neurosci. 16: 7599-7609
WILSON H. C., N. J. SCOLDING, C. S. RAINE (2006):
Co-expression of PDGF α receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions.
Journal of Neuroimmunology; 176: 162-173
B. G. XIAO, H. LINK (1999):
Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?
Immunol. Today 20: 477-479
YAMADA M. u. H. HATANAKA (1994):
Interleukin-6 protects cultured rat hippocampal neurons against glutamate induced cell death.
Brain Res. 643: 173-180
YONG V. W., O. CHABOT, O. STUVE, G. WILLIAMS (1998):
Interferon β in the treatment of multiple sclerosis: mechanisms of action.
Neurology 51: 682
ZLOTKIN S. H., S. ATKINSON (1995):
Trace elements in nutrition for premature infants.
Clin. Perinatol. 22: 223-240